<VariationArchive VariationID="983204" VariationName="NM_001114753.3(ENG):c.496dup (p.Gln166fs)" VariationType="Duplication" Accession="VCV000983204" Version="13" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-05-01" DateCreated="2020-10-31" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="970602" VariationID="983204">
      <GeneList>
        <Gene Symbol="ENG" FullName="endoglin" GeneID="2022" HGNC_ID="HGNC:3349" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q34.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127815016" stop="127854658" display_start="127815016" display_stop="127854658" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="130577290" stop="130617046" display_start="130577290" display_stop="130617046" Strand="-" />
          </Location>
          <OMIM>131195</OMIM>
          <Haploinsufficiency last_evaluated="2024-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ENG">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2024-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ENG">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_001114753.3(ENG):c.496dup (p.Gln166fs)</Name>
      <CanonicalSPDI>NC_000009.12:127826536:GGGGG:GGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9q34.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127826536" stop="127826537" display_start="127826536" display_stop="127826537" variantLength="1" positionVCF="127826536" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="130588815" stop="130588816" display_start="130588815" display_stop="130588816" variantLength="1" positionVCF="130588815" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <OtherNameList>
        <Name>p.Gln166Profs*168</Name>
      </OtherNameList>
      <ProteinChange>Q166fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000118.3" sequenceAccession="NM_000118" sequenceVersion="3" change="c.496_497insC">
            <Expression>NM_000118.3:c.496_497insC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.130588820dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.130588820dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.127826541dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.127826541dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009551.1" sequenceAccession="NG_009551" sequenceVersion="1" change="g.33232dup">
            <Expression>NG_009551.1:g.33232dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000118.4" sequenceAccession="NM_000118" sequenceVersion="4" change="c.492dup">
            <Expression>NM_000118.4:c.492dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000109.1" sequenceAccession="NP_000109" sequenceVersion="1" change="p.Gln166Profs">
            <Expression>NP_000109.1:p.Gln166Profs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114753.3" sequenceAccession="NM_001114753" sequenceVersion="3" change="c.496dup" MANESelect="true">
            <Expression>NM_001114753.3:c.496dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001108225.1" sequenceAccession="NP_001108225" sequenceVersion="1" change="p.Gln166fs">
            <Expression>NP_001108225.1:p.Gln166fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278138.2" sequenceAccession="NM_001278138" sequenceVersion="2" change="c.-51dup">
            <Expression>NM_001278138.2:c.-51dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406715.1" sequenceAccession="NM_001406715" sequenceVersion="1" change="c.492dup">
            <Expression>NM_001406715.1:c.492dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001393644.1" sequenceAccession="NP_001393644" sequenceVersion="1" change="p.Gln166Profs">
            <Expression>NP_001393644.1:p.Gln166Profs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_589" sequenceAccession="LRG_589">
            <Expression>LRG_589:g.33232dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_589t1" sequenceAccession="LRG_589t1">
            <Expression>LRG_589t1:c.496dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_589p1" sequenceAccession="LRG_589p1" change="p.Gln166fs">
            <Expression>LRG_589p1:p.Gln166fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_589t2" sequenceAccession="LRG_589t2">
            <Expression>LRG_589t2:c.492dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_589p2" sequenceAccession="LRG_589p2" change="p.Gln166Profs">
            <Expression>LRG_589p2:p.Gln166Profs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114753.2" sequenceAccession="NM_001114753" sequenceVersion="2" change="c.496dup">
            <Expression>NM_001114753.2:c.496dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1830620247" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001114753.3(ENG):c.496dup (p.Gln166fs) AND Telangiectasia, hereditary hemorrhagic, type 1" Accession="RCV001263076" Version="3">
        <ClassifiedConditionList TraitSetID="7437">
          <ClassifiedCondition DB="MedGen" ID="C4551861">Telangiectasia, hereditary hemorrhagic, type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001114753.3(ENG):c.496dup (p.Gln166fs) AND Cardiovascular phenotype" Accession="RCV002339701" Version="2">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-09-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001114753.3(ENG):c.496dup (p.Gln166fs) AND not provided" Accession="RCV003481041" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001114753.3(ENG):c.496dup (p.Gln166fs) AND Hereditary hemorrhagic telangiectasia" Accession="RCV001390951" Version="8">
        <ClassifiedConditionList TraitSetID="43931">
          <ClassifiedCondition DB="MedGen" ID="C0039445">Hereditary hemorrhagic telangiectasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-10-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-29" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2020-10-31" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15517393</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15879500</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15880681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21158752</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32573726</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="43931" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="40362" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Osler Weber Rendu syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ORW disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osler-Rendu-Weber disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osler hemorrhagic telangiectasia syndrome</ElementValue>
                <XRef ID="Osler+hemorrhagic+telangiectasia+syndrome/9046" DB="Genetic Alliance" />
                <XRef ID="21877004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary hemorrhagic telangiectasia</ElementValue>
                <XRef ID="MONDO:0019180" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HHT</ElementValue>
                <XRef ID="GTR000525320" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="187300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6626" />
                <XRef ID="6626" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000500010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515719" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <XRef ID="774" DB="Orphanet" />
              <XRef ID="C0039445" DB="MedGen" />
              <XRef ID="MONDO:0019180" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS187300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7437" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16695" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Telangiectasia, hereditary hemorrhagic, type 1</ElementValue>
                <XRef ID="MONDO:0008535" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osler Weber Rendu syndrome type 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ORW1</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">HHT1</ElementValue>
                <XRef Type="MIM" ID="187300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000227625" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509787" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553700" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515716" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506221" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528531" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506222" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512361" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500544" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506220" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562015" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511259" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505110" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500545" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528884" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515719" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509788" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.</Attribute>
                <XRef ID="NBK1351" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary Hemorrhagic Telangiectasia</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301525</ID>
                <ID Source="BookShelf">NBK1351</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2011">
                <ID Source="PubMed">19553198</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Shovlin et al., 2000">
                <ID Source="PubMed">10751092</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2020">
                <ID Source="PubMed">32894695</ID>
              </Citation>
              <XRef ID="774" DB="Orphanet" />
              <XRef ID="C4551861" DB="MedGen" />
              <XRef ID="MONDO:0008535" DB="MONDO" />
              <XRef Type="MIM" ID="187300" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2844222" SubmissionDate="2020-05-21" DateLastUpdated="2020-10-31" DateCreated="2020-10-31">
        <ClinVarSubmissionID localKey="ENST00000373203 c.496_497insC|OMIM:187300" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001441156" DateUpdated="2020-10-31" DateCreated="2020-10-31" Type="SCV" Version="1" SubmitterName="NIHR Bioresource Rare Diseases, University of Cambridge" OrgID="505998" OrganizationCategory="consortium" OrgAbbreviation="NIHR BR RD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32573726</ID>
          </Citation>
          <Comment>PVS1+PM2+PP4</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>Next-gen sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ENG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000118.3:c.496_497insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="187300" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ThromboGenomics_HHT</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7898283" SubmissionDate="2023-12-21" DateLastUpdated="2024-01-06" DateCreated="2024-01-06">
        <ClinVarSubmissionID localKey="1727710|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004226819" DateUpdated="2024-01-06" DateCreated="2024-01-06" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15517393</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15879500</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15880681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32573726</ID>
          </Citation>
          <Comment>PP4, PM2_supporting, PS4_moderate, PVS1</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ENG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_001114753.2:exon 4</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Gln166Profs*168</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001114753.2:c.496dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104855</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3118545" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4882586|MedGen:C0039445" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001592857" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15879500</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15517393</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15880681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21158752</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in ENG are known to be pathogenic (PMID: 15879500). This variant has been observed in individual(s) with hereditary hemorrhagic telangiectasia (PMID: 15517393, 15880681, 21158752). This variant is also known as c.497_498insC. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln166Profs*168) in the ENG gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ENG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.130588815_130588816insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0039445" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5126623" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a132341|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002643975" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15517393</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15880681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21158752</ID>
          </Citation>
          <Comment>The c.496dupC pathogenic mutation, located in coding exon 4 of the ENG gene, results from a duplication of C at nucleotide position 496, causing a translational frameshift with a predicted alternate stop codon (p.Q166Pfs*168). This mutation, and a similar c.497_498insC variant, have been reported in individuals with hereditary hemorrhagic telangiectasia (HHT) (Ambry internal data; Schulte C et al. Hum Mutat, 2005 Jun;25:595; Letteboer TG et al. Hum Genet, 2005 Jan;116:8-16; McDonald J et al. Clin Genet, 2011 Apr;79:335-44). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ENG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001114753.1:c.496dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5126623" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3118545" TraitType="Disease" MappingType="XRef" MappingValue="C0039445" MappingRef="MedGen">
        <MedGen CUI="C0039445" Name="Hereditary hemorrhagic telangiectasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2844222" TraitType="Disease" MappingType="XRef" MappingValue="187300" MappingRef="OMIM">
        <MedGen CUI="C4551861" Name="Telangiectasia, hereditary hemorrhagic, type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7898283" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

